Insulet Corporation has announced a significant amendment to its existing credit agreement, effective June 6, 2025. The company has entered into the Eighth Amendment to Credit Agreement with Morgan Stanley Senior Funding, Inc. and other lenders. This amendment replaces $481.25 million of existing term loans with new term loans, offering a reduced interest rate margin by 0.50%. The interest rate for the new term loans is set at 1.00% for base rate loans and 2.00% for term SOFR loans, with a SOFR floor of 0.00%. Additionally, the interest rate margins for revolving facility loans have been reduced, providing Insulet Corporation with more favorable financing terms. The maturity of the revolving credit facility remains unchanged. Wachtell, Lipton, Rosen & Katz served as advisors for Insulet Corporation in these transactions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.